These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The role of membrane transporters in cellular resistance to anticancer nucleoside drugs. Clarke ML; Mackey JR; Baldwin SA; Young JD; Cass CE Cancer Treat Res; 2002; 112():27-47. PubMed ID: 12481710 [No Abstract] [Full Text] [Related]
7. Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents. Klanova M; Lorkova L; Vit O; Maswabi B; Molinsky J; Pospisilova J; Vockova P; Mavis C; Lateckova L; Kulvait V; Vejmelkova D; Jaksa R; Hernandez F; Trneny M; Vokurka M; Petrak J; Klener P Mol Cancer; 2014 Jun; 13():159. PubMed ID: 24972933 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors. Csoka K; Liliemark J; Larsson R; Nygren P Semin Oncol; 1995 Aug; 22(4 Suppl 11):47-53. PubMed ID: 7481845 [TBL] [Abstract][Full Text] [Related]
9. Gemcitabine-induced apoptosis in a drug-resistant mouse leukemia L1210 cell line that does not express p53. Cory AH; Cory JG Adv Enzyme Regul; 2004; 44():11-25. PubMed ID: 15581479 [No Abstract] [Full Text] [Related]
13. Surviving cells after treatment with gemcitabine or 5-fluorouracil for the study of de novo resistance of pancreatic cancer. Liu QH; Zhang J; Zhao CY; Yu DH; Bu HJ; Chen Y; Ni CY; Zhu MH Cancer Lett; 2012 Jan; 314(1):119-25. PubMed ID: 21983131 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of cladribine and gemcitabine on erythroid and granulocytic progenitors from patients with chronic myeloid leukemia. Schirmer M; Geisen F; Tiefenthaler M; Konwalinka G Leuk Res; 1999 Dec; 23(12):1121-6. PubMed ID: 10613357 [TBL] [Abstract][Full Text] [Related]